- Home
- SPCB vs DXR Comparison
SPCB vs DXR Comparison
Compare SPCB & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- DXR
- Stock Information
- Founded
- SPCB 1988
- DXR 1970
- Country
- SPCB Israel
- DXR United States
- Employees
- SPCB N/A
- DXR N/A
- Industry
- SPCB Semiconductors
- DXR Medical/Dental Instruments
- Sector
- SPCB Technology
- DXR Health Care
- Exchange
- SPCB Nasdaq
- DXR Nasdaq
- Market Cap
- SPCB 53.3M
- DXR 46.1M
- IPO Year
- SPCB N/A
- DXR N/A
- Fundamental
- Price
- SPCB $9.23
- DXR $10.08
- Analyst Decision
- SPCB Strong Buy
- DXR Strong Buy
- Analyst Count
- SPCB 1
- DXR 1
- Target Price
- SPCB $18.00
- DXR $25.00
- AVG Volume (30 Days)
- SPCB 98.6K
- DXR 3.2K
- Earning Date
- SPCB 08-14-2025
- DXR 01-01-0001
- Dividend Yield
- SPCB N/A
- DXR N/A
- EPS Growth
- SPCB N/A
- DXR 86.16
- EPS
- SPCB 1.89
- DXR 0.11
- Revenue
- SPCB $27,831,000.00
- DXR $119,714.00
- Revenue This Year
- SPCB $2.73
- DXR N/A
- Revenue Next Year
- SPCB $22.87
- DXR N/A
- P/E Ratio
- SPCB $4.76
- DXR $94.36
- Revenue Growth
- SPCB 2.90
- DXR N/A
- 52 Week Low
- SPCB $2.55
- DXR $6.55
- 52 Week High
- SPCB $18.95
- DXR $10.49
- Technical
- Relative Strength Index (RSI)
- SPCB 42.82
- DXR 60.37
- Support Level
- SPCB $9.00
- DXR $9.11
- Resistance Level
- SPCB $9.59
- DXR $10.49
- Average True Range (ATR)
- SPCB 0.48
- DXR 0.39
- MACD
- SPCB -0.10
- DXR 0.04
- Stochastic Oscillator
- SPCB 14.40
- DXR 72.48
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.